Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 262-967-7 | CAS number: 61788-32-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Carcinogenicity
Administrative data
Description of key information
Terphenyl, hydrogenated was studied for dermal carcinogenicity in mice for 37 weeks under different conditions (once or more times a week; followed by croton oil administration) and in different strains (Balb/c and PLA). All studies were negative, demonstrating that there were no indications for dermal carcinogenicity.
Key value for chemical safety assessment
Carcinogenicity: via dermal route
Endpoint conclusion
- Dose descriptor:
- NOAEL
- 280 mg/kg bw/day
Justification for classification or non-classification
The endpoint does not meet classification criteria according to EU and/or CLPcriteria.
Additional information
Literature studies were available as weight of evidence for carcinogenicity testing for the skin. Terphenyl, hydrogenated was dermally administered from tail to neck over a 2 cm swathe on the back, at a dose of 50mg/week for 37 weeks to male and female Balb/c mice, followed by 22 weeks with croton oil administration (Henderson & Weeks, 1973a). The mice were examined weekly. Each one of the early tumors was drawn as soon as it appeared. The late tumors were drawn during surveys in which whole experiments were depicted at monthly intervals. An autopsy was done on every mouse dying during the experiments and on every survivor at the end. Tissues, excised post mortem or, in a few -instances, during life tinder anaesthesia, were fixed by buffered formalin and stained with hematoxylin and phloxine. There were no abnormal clinical observations, gross pathological observations and histopathological findings. The NOAEL for carcinogenicity was therefore 50 mg/week, corresponding with 280 mg/kg bw/day (50 mg/week = 7 mg/day/25g = 280 mg/kg bw day).
In a second part of the study, Terphenyl, hydrogenated was dermally administered from tail to neck over a 2 cm swathe on the back at 50 mg/week for 37 weeks to male and female Balb/c mice (Henderson & Weeks, 1973b). The mice of one group were painted five times a week, those of another group four times, of another group three times, of another group twice and of the fifth group one once per week. After 14 weeks applications of Terphenyl, hydrogenated were stopped and all were painted thereafter twice weekly with croton oil. The mice were examined weekly. Each one of the early tumors was drawn as soon as it appeared. The late tumors were drawn during surveys in which whole experiments were depicted at monthly intervals. An autopsy was done on every mouse dying during the experiments and on every survivor at the end. Tissues, excised post mortem or, in a few -instances, during life tinder anaesthesia, were fixed by buffered formalin and stained with hematoxylin and phloxine. There were no abnormal gross pathological observations and histopathological findings. All the Terphenyl, hydrogenated painted mice continued to grow hair; the dorsal fur of those most painted was difficult to clip and it formed a matted shield for the skin beneath. No skin tumor resulted. The NOAEL for carcinogenicity was 50 mg/week, corresponding with 280 mg/kg bw/day.
Finally, Terphenyl, hydrogenated was dermally administered from tail to neck over a 2 cm swathe on the back, at a dose of once a week 50 mg for 37 weeks to male and female PLA mice (Henderson & Weeks, 1973c). The mice were examined weekly. Each one of the early tumors was drawn as soon as it appeared. The late tumors were drawn during surveys in which whole experiments were depicted at monthly intervals. An autopsy was done on every mouse dying during the experiments and on every survivor at the end. Tissues, excised post mortem or, in a few -instances, during life under anaesthesia, were fixed by buffered formalin and stained with hematoxylin and phloxine. There were no abnormal clinical observations, gross pathological observations and histopathological findings. The NOAEL for carcinogenicity was therefore 50 mg/week, corresponding with 280 mg/kg bw/day.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
